Corrigendum: Cutaneous kinase activity correlates with treatment outcomes following PI3K delta inhibition in mice with experimental pemphigoid diseases
Saeedeh Ghorbanalipoor(University of Lübeck), Ralf J. Ludwig(University of Lübeck), Katharina Boch(University of Lübeck), Ibrahim O. Ibrahim(University of Lübeck), Shirin Emtenani(Institute for Integrative and Experimental Genomics), Natalie Gross(University of Lübeck), Diana D. J. Wortmann(University of Lübeck), Mayumi Kamaguchi(University of Lübeck), Stanislav Khil’chenko(University of Lübeck), Manuela Pigors(University of Lübeck), Colin Osterloh(University of Lübeck), Katja Bieber(University of Lübeck), Stephanie Goletz(University of Lübeck), Melissa Parker(Incyte (United States)), Enno Schmidt(University Hospital Schleswig-Holstein), Sabrina Patzelt(University of Lübeck), Kentaro Izumi(University of Lübeck), Kathrin Kalies(University of Lübeck), Paul Smith(Incyte (United States)), Anika Kasprick(University of Lübeck)
Cited by 7
Related Papers
Psoriasis: a possible risk factor for development of coronary artery calcification
|British Journal of Dermatology|2006|376
Diagnosis and management of pemphigus: Recommendations of an international panel of experts
|Journal of the American Academy of Dermatology|2018|373
Definitions and outcome measures for bullous pemphigoid: Recommendations by an international panel of experts
|Journal of the American Academy of Dermatology|2011|370
Updated S2K guidelines on the management of pemphigus vulgaris and foliaceus initiated by the european academy of dermatology and venereology (EADV)
|Journal of the European Academy of Dermatology and Venereology|2020|332